IL-10 antibody (FineTest®488)
Quick Overview for IL-10 antibody (FineTest®488) (ABIN7675262)
Target
See all IL-10 (IL10) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- FineTest®488 Anti-Human IL-10 Antibody
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Volume per test: 5μL. Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0. 1 % sodium azide, 1 %BSA, pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- IL-10 (IL10) (Interleukin 10 (IL10))
-
Alternative Name
- IL-10
-
Background
-
Synonyms: CSIF|Cytokine synthesis inhibitory factor|IL-10|Interleukin-10
Background: IL-10 was originally described as Cytokine Synthesis Inhibitory Factor (CSIF) by virtue of its ability to inhibit cytokine production by Th1 clones. IL-10 shares over 80 % sequence homology with the Epstein-Barr virus protein BCRFI. The biological activities of IL-10 include inhibition of macrophage-mediated cytokine synthesis, suppression of the delayed type hypersensitivity response, and stimulation of the Th2 cell response, which results in elevated antibody production.
-
Molecular Weight
- 0
-
Gene ID
- 3586
-
UniProt
- P22301
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
Target
-